Besides, a suggestive relationship between E2F3 and survival indicated that a greater expression difference of E2F3 between normal and tumor tissue will possibly predict shorter survival of the patient affected by HNSCC (22). This evidence concerns the gene E2F3 and head and neck squamous cell carcinoma.